Joseph S Zakrzewski's Net Worth

$45.3 Million

Estimate Recalculated Sep 12, 2024 03:10PM EST

Who is Joseph S Zakrzewski?

Joseph S Zakrzewski has an estimated net worth of $45.3 Million. This is based on reported shares across multiple companies, which include AN2 Therapeutics, Inc., INSULET CORP, AMARIN CORP PLC\UK, SANGAMO THERAPEUTICS, INC, Cyteir Therapeutics, Inc., ACCELERON PHARMA INC, LIPOSCIENCE INC, and DOV PHARMACEUTICAL INC.

SEC CIK

Joseph S Zakrzewski's CIK is 0001331852

Past Insider Trading and Trends

2021 was Joseph S Zakrzewski's most active year for acquiring shares with 17 total transactions. Joseph S Zakrzewski's most active month to acquire stocks was the month of May. 2021 was Joseph S Zakrzewski's most active year for disposing of shares, totalling 17 transactions. Joseph S Zakrzewski's most active month to dispose stocks was the month of March. 2018 saw Joseph S Zakrzewski paying a total of $1,700,000.00 for 604,376 shares, this is the most they've acquired in one year. In 2020 Joseph S Zakrzewski cashed out on 718,750 shares for a total of $6,282,870.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AN2 Therapeutics, Inc. (ANTX) Snapshot price: $1.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 19
Form 4
-19.77%
-100.00K
$19.11
-$1,911,410.00
405.88K
Jan 18
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
May 12
Form 4
∞
98.2K
—
—
98.2K
Mar 29
Form 3
—
0
—
—
0
No matching records found

INSULET CORP (PODD) Snapshot price: $214.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9.73%
2.71K
—
—
30.56K
May 17
Form 4
—
0
$29.95
-$1,353,005.79
27.85K
Mar 2
Form 4
+15.85%
3.81K
—
—
27.85K
May 11
Form 4
+20.20%
4.04K
—
—
24.04K
May 13
Form 4
+25.00%
4K
—
—
20K
Jun 2
Form 4
+33.33%
4K
—
—
16K
Jun 3
Form 4
+50.00%
4K
—
—
12K
Jun 1
Form 4
-38.46%
-5.00K
$20.39
-$101,935.30
8K
Feb 16 - Feb 17
Form 4
+44.44%
4K
—
—
13K
May 12
Form 4
+80.00%
4K
—
—
9K
Jun 1
Form 4
—
0
—
—
0
Jul 30
Form 4
∞
5K
$4.71
$23,550.00
5K
Nov 11
Form 4
—
0
—
—
0
May 8
Form 3
—
0
—
—
0
No matching records found

AMARIN CORP PLC\UK (AMRN) Snapshot price: $0.6094

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.50%
12K
$3.25
$38,999.00
196.55K
Dec 14 - Dec 15
Form 4
—
0
—
—
0
Jun 14
Form 4
+118.28%
100K
$3.40
$340,000.00
184.55K
Oct 21
Form 4
—
0
—
—
0
Jul 13
Form 4
—
0
$12.17
-$5,262,870.00
84.55K
Scheduled
Jan 3
Form 4
—
0
$17.42
-$1,683,380.00
84.55K
Scheduled
Dec 16
Form 4
—
0
$16.41
-$1,481,580.00
84.55K
Scheduled
Jul 5
Form 4
—
0
$11.21
-$1,562,090.00
84.55K
Scheduled
Jun 18
Form 4
—
0
—
—
0
May 20
Form 4
—
0
$14.30
-$2,022,125.00
84.55K
Scheduled
Feb 22
Form 4
—
0
$10.19
-$2,716,390.00
84.55K
Scheduled
Jan 10
Form 4
-62.60%
-141.50K
$8.14
-$5,645,121.00
84.55K
Scheduled
Dec 28 - Jan 2
Form 4
—
0
—
—
0
May 14
Form 4
—
0
$7.00
-$3,599,333.58
226.05K
Scheduled
Sep 24
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
Jul 11
Form 4
—
0
—
—
0
Jul 6
Form 4
—
0
—
—
0
Mar 11
Form 4
+28.97%
50.78K
$1.54
$78,196.58
226.05K
Nov 18
Form 4
+23.48%
33.33K
—
—
175.27K
Jul 26
Form 4
+7.58%
10K
$1.35
$13,500.00
141.94K
Jun 25
Form 4
+8.20%
10K
$1.35
$13,500.00
131.94K
Jun 21
Form 4
+8.93%
10K
$1.35
$13,500.00
121.94K
Apr 25
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
$6.96
-$1,681,815.00
111.94K
Scheduled
Oct 1
Form 4
+42.41%
33.33K
$7.83
-$1,944,692.46
111.94K
Scheduled
Jul 26 - Jul 27
Form 4
—
0
$6.66
-$1,592,715.00
78.6K
Scheduled
May 29
Form 4
—
0
$6.47
-$1,638,560.00
78.6K
Mar 23
Form 4
—
0
—
—
0
Feb 1
Form 4
+6.79%
5K
$1.35
$6,750.00
78.6K
Nov 7
Form 4
—
0
—
—
0
Oct 20
Form 4
+7.29%
5K
$1.35
$6,750.00
73.6K
Aug 22
Form 4/A
+7.86%
5K
$1.35
$6,750.00
68.6K
Jul 15
Form 4
+7.86%
5K
$1.35
$6,750.00
68.6K
Jul 15
Form 4
—
0
$9.24
-$3,913,210.00
63.6K
Scheduled
Apr 18
Form 4
+18.66%
10K
$1.35
$13,500.00
63.6K
Mar 9
Form 4
—
0
$4.76
-$408,755.00
53.6K
Feb 25
Form 4
—
0
$4.94
-$719,060.00
53.6K
Scheduled
Feb 22
Form 3
—
0
—
—
0
No matching records found

SANGAMO THERAPEUTICS, INC (SGMO) Snapshot price: $0.72

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+25.93%
12.5K
—
—
60.7K
Feb 25
Form 4
+20.50%
8.2K
—
—
48.2K
Feb 25
Form 4/A
+33.33%
10K
—
—
40K
May 18
Form 4
+8.33%
2.5K
—
—
32.5K
May 18
Form 4
+20.00%
5K
$4.99
$24,950.00
30K
Mar 17
Form 4
+400.00%
20K
$6.15
$123,000.00
25K
Mar 12 - Mar 13
Form 4
+100.00%
2.5K
—
—
5K
Jun 10
Form 4
∞
2.5K
—
—
2.5K
Jun 11
Form 4
—
0
—
—
0
Jun 27
Form 3
—
0
—
—
0
No matching records found

Cyteir Therapeutics, Inc. (CYT) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.63%
14.15K
$1.69
$23,913.50
227.44K
Feb 6
Form 4
—
0
—
—
0
Feb 3
Form 4/A
—
0
—
—
0
Form 4
+15.89%
21.2K
$1.30
$27,562.60
154.62K
Dec 7
Form 4
+0.56%
743
$1.61
$1,196.23
133.42K
May 12
Form 4
+61.27%
50.41K
$1.89
$95,077.34
132.67K
May 10 - May 11
Form 4
—
0
—
—
0
Feb 22
Form 4
+1.36%
1.1K
$9.91
$10,895.67
82.27K
Dec 23 - Dec 28
Form 4
+0.25%
200
$9.88
$1,976.00
81.17K
Dec 17
Form 4
+4.79%
3.7K
$10.77
$39,844.00
80.97K
Dec 15
Form 4
∞
58.67K
—
—
58.67K
Jun 22
Form 3
—
0
—
—
0
No matching records found